Physician profile
Grigor Varlakov
NPI 1083812994
$2,399.83
in general payments reported to CMS, 2019-2025
17 companies · $76.03 in 2025
The $76.03 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,871 · 2020: $84.82 · 2022: $91.28 · 2023: $277 · 2025: $76.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $483.35 | 2019-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Amgen INC. | $348.81 | 2019 | |
| Lilly USA, LLC | $297.02 | 2019 | |
| Amarin Pharma, INC. | $284.95 | 2019-2020 | |
| Novo Nordisk INC | $210.19 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.74 | 2019 | |
| Janssen Pharmaceuticals, INC | $140.36 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $118.65 | 2019 | |
| Horizon Therapeutics Plc | $81.79 | 2019 | |
| Medtronic Vascular, INC. | $76.28 | 2019 | |
| Emergent Biosolutions INC. | $56.96 | 2019 | |
| Astellas Pharma US INC | $43.61 | 2019 | |
| Edwards Lifesciences Corporation | $32.58 | 2025 | Sapien 3 Ultra Resilia |
| Tactile Systems Technology INC | $24.35 | 2025 | Flexitouch Plus, Nimbl |
| Sanofi-Aventis U.S. LLC | $21.87 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.10 | 2025 | |
| Novartis Pharmaceuticals Corporation | $16.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grigor Varlakov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.